HopeStage
Back to all studies
RecruitingNCT07290153

Psychological well-being and immunotherapy response in triple-negative breast cancer

About this titleRead the official source — NCT07290153
Observational studyAges 18–70ChinaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
ShanghaiSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: January 1, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
Fudan University
Sponsor type
University
Study type
Observational
Intervention type
Interview / survey / observational
Locations
China
Age range
From 18 Years to 70 Years
Official registry ID
NCT07290153
Official title
Show the full official title

Prospective Observational Study of Psychological State, Immunotherapy Response, and Multi-Omics Features in Triple-Negative Breast Cancer

Recruitment & locations

Currently recruiting

Shanghai

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Fudan University, a university.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies